An open trial of topical tacrolimus for erosive oral lichen planus

J Am Acad Dermatol. 2002 Oct;47(4):617-20. doi: 10.1067/mjd.2002.126275.

Abstract

Erosive oral lichen planus is a chronic, painful disease that is frequently refractory to treatment. We describe 6 patients with erosive oral lichen planus, not responsive to topical steroids, who showed substantial improvement with the use of topical tacrolimus ointment 0.1%. This medication was well tolerated and appears to be effective in controlling erosive oral lichen planus.

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Topical
  • Adult
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use*
  • Lichen Planus, Oral / blood
  • Lichen Planus, Oral / drug therapy*
  • Male
  • Tacrolimus / administration & dosage
  • Tacrolimus / blood
  • Tacrolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Tacrolimus